Medical Care
Global Post herpetic Neuralgia Treatment Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jul 08, 25
- ID: 362780
- Pages: 119
- Figures: 129
- Views: 2
In 2024, the global market size of Post herpetic Neuralgia Treatment was estimated to be worth US$ 1714 million and is forecast to reach approximately US$ 2247 million by 2031 with a CAGR of 4.0% during the forecast period 2025-2031.
Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for post herpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.
Global Post herpetic Neuralgia Treatment key players include Pfizer, Arbor Pharma, Assertio Therapeutics, Endo Pharma, Teikoku Pharma, etc. Global top five manufacturers hold a share about 80%.
North America is the largest market, with a share over 50%, followed by Europe and China, both have a share about 30 percent.
In terms of product, Anticonvulsants is the largest segment, with a share over 80%. And in terms of distribution channel, the largest distribution channel is Hospital Pharmacies, followed by Retail Pharmacies.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Post herpetic Neuralgia Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Post herpetic Neuralgia Treatment.
The Post herpetic Neuralgia Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Post herpetic Neuralgia Treatment market comprehensively. Regional market sizes, concerning products by Type, by Distribution Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Post herpetic Neuralgia Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Pfizer
Arbor Pharma
Assertio Therapeutics
Endo Pharma
Teikoku Pharma
Teva
Mylan
Hengrui Medicine
Segment by Type
Anticonvulsants
Skin Patch
Other
Segment by Distribution Channel
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Post herpetic Neuralgia Treatment in global and regional level.
Chapter 3: Detailed analysis of Post herpetic Neuralgia Treatment company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Post herpetic Neuralgia Treatment revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Distribution Channel, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Distribution Channel and by country, revenue for each segment.
Chapter 8: Europe by Type, by Distribution Channel and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Distribution Channel and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Distribution Channel and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Distribution Channel and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for post herpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.
Global Post herpetic Neuralgia Treatment key players include Pfizer, Arbor Pharma, Assertio Therapeutics, Endo Pharma, Teikoku Pharma, etc. Global top five manufacturers hold a share about 80%.
North America is the largest market, with a share over 50%, followed by Europe and China, both have a share about 30 percent.
In terms of product, Anticonvulsants is the largest segment, with a share over 80%. And in terms of distribution channel, the largest distribution channel is Hospital Pharmacies, followed by Retail Pharmacies.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Post herpetic Neuralgia Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Post herpetic Neuralgia Treatment.
The Post herpetic Neuralgia Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Post herpetic Neuralgia Treatment market comprehensively. Regional market sizes, concerning products by Type, by Distribution Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Post herpetic Neuralgia Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Pfizer
Arbor Pharma
Assertio Therapeutics
Endo Pharma
Teikoku Pharma
Teva
Mylan
Hengrui Medicine
Segment by Type
Anticonvulsants
Skin Patch
Other
Segment by Distribution Channel
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Post herpetic Neuralgia Treatment in global and regional level.
Chapter 3: Detailed analysis of Post herpetic Neuralgia Treatment company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Post herpetic Neuralgia Treatment revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Distribution Channel, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Distribution Channel and by country, revenue for each segment.
Chapter 8: Europe by Type, by Distribution Channel and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Distribution Channel and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Distribution Channel and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Distribution Channel and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
1 Study Coverage
1.1 Post herpetic Neuralgia Treatment Product Introduction
1.2 Market by Type
1.2.1 Global Post herpetic Neuralgia Treatment Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Anticonvulsants
1.2.3 Skin Patch
1.2.4 Other
1.3 Market by Distribution Channel
1.3.1 Global Post herpetic Neuralgia Treatment Market Size Growth Rate by Distribution Channel (2020 VS 2024 VS 2031)
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Post herpetic Neuralgia Treatment Market Size Estimates and Forecasts
2.2 Post herpetic Neuralgia Treatment Market Size by Region: 2024 Versus 2031
2.2.1 Global Post herpetic Neuralgia Treatment Revenue by Region: 2020-2025
2.2.2 Global Post herpetic Neuralgia Treatment Revenue Forecast by Region (2026-2031)
2.2.3 Global Post herpetic Neuralgia Treatment Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Post herpetic Neuralgia Treatment Revenue by Type (2020-2031)
3.1.2 Global Post herpetic Neuralgia Treatment Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Distribution Channel
3.2.1 Global Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2020-2031)
3.2.2 Global Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel (2020-2031)
3.3 by Type and by Distribution Channel Crossing Analysis
3.3.1 Anticonvulsants of Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel
3.3.2 Skin Patch of Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel
3.3.3 Other of Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel
4 Global Post herpetic Neuralgia Treatment by Company
4.1 Global Post herpetic Neuralgia Treatment Revenue by Company (2020-2025)
4.2 Global Post herpetic Neuralgia Treatment Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Post herpetic Neuralgia Treatment Companies around the World: Ranking by Revenue
4.3.2 Global Post herpetic Neuralgia Treatment Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Post herpetic Neuralgia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Post herpetic Neuralgia Treatment Companies Headquarters & Product Type
4.4.1 Global Post herpetic Neuralgia Treatment Companies Headquarters
4.4.2 Date of International Companies Enter into Post herpetic Neuralgia Treatment Market
4.4.3 Global Post herpetic Neuralgia Treatment Companies Product & Service
4.4.4 Anticonvulsants Revenue Market Share of Post herpetic Neuralgia Treatment by Company
4.4.5 Skin Patch Revenue Market Share of Post herpetic Neuralgia Treatment by Company
4.4.6 Other Revenue Market Share of Post herpetic Neuralgia Treatment by Company
4.5 Global Post herpetic Neuralgia Treatment Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Pfizer
5.1.1 Pfizer Corporation Information
5.1.2 Pfizer Description, Business Overview
5.1.3 Pfizer Post herpetic Neuralgia Treatment Products Offered
5.1.4 Pfizer Post herpetic Neuralgia Treatment Revenue and Gross Margin (2020-2025)
5.1.5 Pfizer Post herpetic Neuralgia Treatment Revenue by Product in 2024
5.1.6 Pfizer Post herpetic Neuralgia Treatment Revenue by Distribution Channel in 2024
5.1.7 Pfizer Post herpetic Neuralgia Treatment Revenue by Geographic Area in 2024
5.1.8 Pfizer Recent Developments
5.2 Arbor Pharma
5.2.1 Arbor Pharma Corporation Information
5.2.2 Arbor Pharma Description, Business Overview
5.2.3 Arbor Pharma Post herpetic Neuralgia Treatment Products Offered
5.2.4 Arbor Pharma Post herpetic Neuralgia Treatment Revenue and Gross Margin (2020-2025)
5.2.5 Arbor Pharma Post herpetic Neuralgia Treatment Revenue by Product in 2024
5.2.6 Arbor Pharma Post herpetic Neuralgia Treatment Revenue by Distribution Channel in 2024
5.2.7 Arbor Pharma Post herpetic Neuralgia Treatment Revenue by Geographic Area in 2024
5.2.8 Arbor Pharma Recent Developments
5.3 Assertio Therapeutics
5.3.1 Assertio Therapeutics Corporation Information
5.3.2 Assertio Therapeutics Description, Business Overview
5.3.3 Assertio Therapeutics Post herpetic Neuralgia Treatment Products Offered
5.3.4 Assertio Therapeutics Post herpetic Neuralgia Treatment Revenue and Gross Margin (2020-2025)
5.3.5 Assertio Therapeutics Post herpetic Neuralgia Treatment Revenue by Product in 2024
5.3.6 Assertio Therapeutics Post herpetic Neuralgia Treatment Revenue by Distribution Channel in 2024
5.3.7 Assertio Therapeutics Post herpetic Neuralgia Treatment Revenue by Geographic Area in 2024
5.3.8 Assertio Therapeutics Recent Developments
5.4 Endo Pharma
5.4.1 Endo Pharma Corporation Information
5.4.2 Endo Pharma Description, Business Overview
5.4.3 Endo Pharma Post herpetic Neuralgia Treatment Products Offered
5.4.4 Endo Pharma Post herpetic Neuralgia Treatment Revenue and Gross Margin (2020-2025)
5.4.5 Endo Pharma Post herpetic Neuralgia Treatment Revenue by Product in 2024
5.4.6 Endo Pharma Post herpetic Neuralgia Treatment Revenue by Distribution Channel in 2024
5.4.7 Endo Pharma Post herpetic Neuralgia Treatment Revenue by Geographic Area in 2024
5.4.8 Endo Pharma Recent Developments
5.5 Teikoku Pharma
5.5.1 Teikoku Pharma Corporation Information
5.5.2 Teikoku Pharma Description, Business Overview
5.5.3 Teikoku Pharma Post herpetic Neuralgia Treatment Products Offered
5.5.4 Teikoku Pharma Post herpetic Neuralgia Treatment Revenue and Gross Margin (2020-2025)
5.5.5 Teikoku Pharma Post herpetic Neuralgia Treatment Revenue by Product in 2024
5.5.6 Teikoku Pharma Post herpetic Neuralgia Treatment Revenue by Distribution Channel in 2024
5.5.7 Teikoku Pharma Post herpetic Neuralgia Treatment Revenue by Geographic Area in 2024
5.5.8 Teikoku Pharma Recent Developments
5.6 Teva
5.6.1 Teva Corporation Information
5.6.2 Teva Description, Business Overview
5.6.3 Teva Post herpetic Neuralgia Treatment Products Offered
5.6.4 Teva Post herpetic Neuralgia Treatment Revenue and Gross Margin (2020-2025)
5.6.5 Teva Post herpetic Neuralgia Treatment Revenue by Product in 2024
5.6.6 Teva Post herpetic Neuralgia Treatment Revenue by Distribution Channel in 2024
5.6.7 Teva Post herpetic Neuralgia Treatment Revenue by Geographic Area in 2024
5.6.8 Teva Recent Developments
5.7 Mylan
5.7.1 Mylan Corporation Information
5.7.2 Mylan Description, Business Overview
5.7.3 Mylan Post herpetic Neuralgia Treatment Products Offered
5.7.4 Mylan Post herpetic Neuralgia Treatment Revenue and Gross Margin (2020-2025)
5.7.5 Mylan Post herpetic Neuralgia Treatment Revenue by Product in 2024
5.7.6 Mylan Post herpetic Neuralgia Treatment Revenue by Distribution Channel in 2024
5.7.7 Mylan Post herpetic Neuralgia Treatment Revenue by Geographic Area in 2024
5.7.8 Mylan Recent Developments
5.8 Hengrui Medicine
5.8.1 Hengrui Medicine Corporation Information
5.8.2 Hengrui Medicine Description, Business Overview
5.8.3 Hengrui Medicine Post herpetic Neuralgia Treatment Products Offered
5.8.4 Hengrui Medicine Post herpetic Neuralgia Treatment Revenue and Gross Margin (2020-2025)
5.8.5 Hengrui Medicine Post herpetic Neuralgia Treatment Revenue by Product in 2024
5.8.6 Hengrui Medicine Post herpetic Neuralgia Treatment Revenue by Distribution Channel in 2024
5.8.7 Hengrui Medicine Post herpetic Neuralgia Treatment Revenue by Geographic Area in 2024
5.8.8 Hengrui Medicine Recent Developments
6 North America
6.1 North America Post herpetic Neuralgia Treatment Market Size YoY Growth 2020-2031
6.2 North America Post herpetic Neuralgia Treatment Market Facts & Figures by Country (2020-2031)
6.3 North America Post herpetic Neuralgia Treatment Revenue by Type (2020-2025)
6.4 North America Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Post herpetic Neuralgia Treatment Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Post herpetic Neuralgia Treatment Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Post herpetic Neuralgia Treatment Revenue by Type (2020-2025)
7.4 Asia-Pacific Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2020-2025)
8 Europe
8.1 Europe Post herpetic Neuralgia Treatment Market Size YoY Growth 2020-2031
8.2 Europe Post herpetic Neuralgia Treatment Market Facts & Figures by Country (2020-2031)
8.3 Europe Post herpetic Neuralgia Treatment Revenue by Type (2020-2025)
8.4 Europe Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2020-2025)
9 Latin America
9.1 Latin America Post herpetic Neuralgia Treatment Market Size YoY Growth 2020-2031
9.2 Latin America Post herpetic Neuralgia Treatment Market Facts & Figures by Country (2020-2031)
9.3 Latin America Post herpetic Neuralgia Treatment Revenue by Type (2020-2025)
9.4 Latin America Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2020-2025)
10 Middle East and Africa
10.1 Latin America Post herpetic Neuralgia Treatment Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Post herpetic Neuralgia Treatment Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Post herpetic Neuralgia Treatment Revenue by Type (2020-2025)
10.4 Middle East and Africa Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Post herpetic Neuralgia Treatment Supply Chain Analysis
11.2 Post herpetic Neuralgia Treatment Key Raw Materials and Upstream Suppliers
11.3 Post herpetic Neuralgia Treatment Clients Analysis
11.4 Post herpetic Neuralgia Treatment Sales Channel and Sales Model Analysis
11.4.1 Post herpetic Neuralgia Treatment Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Post herpetic Neuralgia Treatment Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Post herpetic Neuralgia Treatment Distributors
12 Post herpetic Neuralgia Treatment Market Dynamics
12.1 Post herpetic Neuralgia Treatment Industry Trends
12.2 Post herpetic Neuralgia Treatment Market Drivers
12.3 Post herpetic Neuralgia Treatment Market Challenges
12.4 Post herpetic Neuralgia Treatment Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Post herpetic Neuralgia Treatment Product Introduction
1.2 Market by Type
1.2.1 Global Post herpetic Neuralgia Treatment Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Anticonvulsants
1.2.3 Skin Patch
1.2.4 Other
1.3 Market by Distribution Channel
1.3.1 Global Post herpetic Neuralgia Treatment Market Size Growth Rate by Distribution Channel (2020 VS 2024 VS 2031)
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Post herpetic Neuralgia Treatment Market Size Estimates and Forecasts
2.2 Post herpetic Neuralgia Treatment Market Size by Region: 2024 Versus 2031
2.2.1 Global Post herpetic Neuralgia Treatment Revenue by Region: 2020-2025
2.2.2 Global Post herpetic Neuralgia Treatment Revenue Forecast by Region (2026-2031)
2.2.3 Global Post herpetic Neuralgia Treatment Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Post herpetic Neuralgia Treatment Revenue by Type (2020-2031)
3.1.2 Global Post herpetic Neuralgia Treatment Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Distribution Channel
3.2.1 Global Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2020-2031)
3.2.2 Global Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel (2020-2031)
3.3 by Type and by Distribution Channel Crossing Analysis
3.3.1 Anticonvulsants of Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel
3.3.2 Skin Patch of Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel
3.3.3 Other of Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel
4 Global Post herpetic Neuralgia Treatment by Company
4.1 Global Post herpetic Neuralgia Treatment Revenue by Company (2020-2025)
4.2 Global Post herpetic Neuralgia Treatment Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Post herpetic Neuralgia Treatment Companies around the World: Ranking by Revenue
4.3.2 Global Post herpetic Neuralgia Treatment Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Post herpetic Neuralgia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Post herpetic Neuralgia Treatment Companies Headquarters & Product Type
4.4.1 Global Post herpetic Neuralgia Treatment Companies Headquarters
4.4.2 Date of International Companies Enter into Post herpetic Neuralgia Treatment Market
4.4.3 Global Post herpetic Neuralgia Treatment Companies Product & Service
4.4.4 Anticonvulsants Revenue Market Share of Post herpetic Neuralgia Treatment by Company
4.4.5 Skin Patch Revenue Market Share of Post herpetic Neuralgia Treatment by Company
4.4.6 Other Revenue Market Share of Post herpetic Neuralgia Treatment by Company
4.5 Global Post herpetic Neuralgia Treatment Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Pfizer
5.1.1 Pfizer Corporation Information
5.1.2 Pfizer Description, Business Overview
5.1.3 Pfizer Post herpetic Neuralgia Treatment Products Offered
5.1.4 Pfizer Post herpetic Neuralgia Treatment Revenue and Gross Margin (2020-2025)
5.1.5 Pfizer Post herpetic Neuralgia Treatment Revenue by Product in 2024
5.1.6 Pfizer Post herpetic Neuralgia Treatment Revenue by Distribution Channel in 2024
5.1.7 Pfizer Post herpetic Neuralgia Treatment Revenue by Geographic Area in 2024
5.1.8 Pfizer Recent Developments
5.2 Arbor Pharma
5.2.1 Arbor Pharma Corporation Information
5.2.2 Arbor Pharma Description, Business Overview
5.2.3 Arbor Pharma Post herpetic Neuralgia Treatment Products Offered
5.2.4 Arbor Pharma Post herpetic Neuralgia Treatment Revenue and Gross Margin (2020-2025)
5.2.5 Arbor Pharma Post herpetic Neuralgia Treatment Revenue by Product in 2024
5.2.6 Arbor Pharma Post herpetic Neuralgia Treatment Revenue by Distribution Channel in 2024
5.2.7 Arbor Pharma Post herpetic Neuralgia Treatment Revenue by Geographic Area in 2024
5.2.8 Arbor Pharma Recent Developments
5.3 Assertio Therapeutics
5.3.1 Assertio Therapeutics Corporation Information
5.3.2 Assertio Therapeutics Description, Business Overview
5.3.3 Assertio Therapeutics Post herpetic Neuralgia Treatment Products Offered
5.3.4 Assertio Therapeutics Post herpetic Neuralgia Treatment Revenue and Gross Margin (2020-2025)
5.3.5 Assertio Therapeutics Post herpetic Neuralgia Treatment Revenue by Product in 2024
5.3.6 Assertio Therapeutics Post herpetic Neuralgia Treatment Revenue by Distribution Channel in 2024
5.3.7 Assertio Therapeutics Post herpetic Neuralgia Treatment Revenue by Geographic Area in 2024
5.3.8 Assertio Therapeutics Recent Developments
5.4 Endo Pharma
5.4.1 Endo Pharma Corporation Information
5.4.2 Endo Pharma Description, Business Overview
5.4.3 Endo Pharma Post herpetic Neuralgia Treatment Products Offered
5.4.4 Endo Pharma Post herpetic Neuralgia Treatment Revenue and Gross Margin (2020-2025)
5.4.5 Endo Pharma Post herpetic Neuralgia Treatment Revenue by Product in 2024
5.4.6 Endo Pharma Post herpetic Neuralgia Treatment Revenue by Distribution Channel in 2024
5.4.7 Endo Pharma Post herpetic Neuralgia Treatment Revenue by Geographic Area in 2024
5.4.8 Endo Pharma Recent Developments
5.5 Teikoku Pharma
5.5.1 Teikoku Pharma Corporation Information
5.5.2 Teikoku Pharma Description, Business Overview
5.5.3 Teikoku Pharma Post herpetic Neuralgia Treatment Products Offered
5.5.4 Teikoku Pharma Post herpetic Neuralgia Treatment Revenue and Gross Margin (2020-2025)
5.5.5 Teikoku Pharma Post herpetic Neuralgia Treatment Revenue by Product in 2024
5.5.6 Teikoku Pharma Post herpetic Neuralgia Treatment Revenue by Distribution Channel in 2024
5.5.7 Teikoku Pharma Post herpetic Neuralgia Treatment Revenue by Geographic Area in 2024
5.5.8 Teikoku Pharma Recent Developments
5.6 Teva
5.6.1 Teva Corporation Information
5.6.2 Teva Description, Business Overview
5.6.3 Teva Post herpetic Neuralgia Treatment Products Offered
5.6.4 Teva Post herpetic Neuralgia Treatment Revenue and Gross Margin (2020-2025)
5.6.5 Teva Post herpetic Neuralgia Treatment Revenue by Product in 2024
5.6.6 Teva Post herpetic Neuralgia Treatment Revenue by Distribution Channel in 2024
5.6.7 Teva Post herpetic Neuralgia Treatment Revenue by Geographic Area in 2024
5.6.8 Teva Recent Developments
5.7 Mylan
5.7.1 Mylan Corporation Information
5.7.2 Mylan Description, Business Overview
5.7.3 Mylan Post herpetic Neuralgia Treatment Products Offered
5.7.4 Mylan Post herpetic Neuralgia Treatment Revenue and Gross Margin (2020-2025)
5.7.5 Mylan Post herpetic Neuralgia Treatment Revenue by Product in 2024
5.7.6 Mylan Post herpetic Neuralgia Treatment Revenue by Distribution Channel in 2024
5.7.7 Mylan Post herpetic Neuralgia Treatment Revenue by Geographic Area in 2024
5.7.8 Mylan Recent Developments
5.8 Hengrui Medicine
5.8.1 Hengrui Medicine Corporation Information
5.8.2 Hengrui Medicine Description, Business Overview
5.8.3 Hengrui Medicine Post herpetic Neuralgia Treatment Products Offered
5.8.4 Hengrui Medicine Post herpetic Neuralgia Treatment Revenue and Gross Margin (2020-2025)
5.8.5 Hengrui Medicine Post herpetic Neuralgia Treatment Revenue by Product in 2024
5.8.6 Hengrui Medicine Post herpetic Neuralgia Treatment Revenue by Distribution Channel in 2024
5.8.7 Hengrui Medicine Post herpetic Neuralgia Treatment Revenue by Geographic Area in 2024
5.8.8 Hengrui Medicine Recent Developments
6 North America
6.1 North America Post herpetic Neuralgia Treatment Market Size YoY Growth 2020-2031
6.2 North America Post herpetic Neuralgia Treatment Market Facts & Figures by Country (2020-2031)
6.3 North America Post herpetic Neuralgia Treatment Revenue by Type (2020-2025)
6.4 North America Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Post herpetic Neuralgia Treatment Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Post herpetic Neuralgia Treatment Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Post herpetic Neuralgia Treatment Revenue by Type (2020-2025)
7.4 Asia-Pacific Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2020-2025)
8 Europe
8.1 Europe Post herpetic Neuralgia Treatment Market Size YoY Growth 2020-2031
8.2 Europe Post herpetic Neuralgia Treatment Market Facts & Figures by Country (2020-2031)
8.3 Europe Post herpetic Neuralgia Treatment Revenue by Type (2020-2025)
8.4 Europe Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2020-2025)
9 Latin America
9.1 Latin America Post herpetic Neuralgia Treatment Market Size YoY Growth 2020-2031
9.2 Latin America Post herpetic Neuralgia Treatment Market Facts & Figures by Country (2020-2031)
9.3 Latin America Post herpetic Neuralgia Treatment Revenue by Type (2020-2025)
9.4 Latin America Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2020-2025)
10 Middle East and Africa
10.1 Latin America Post herpetic Neuralgia Treatment Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Post herpetic Neuralgia Treatment Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Post herpetic Neuralgia Treatment Revenue by Type (2020-2025)
10.4 Middle East and Africa Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Post herpetic Neuralgia Treatment Supply Chain Analysis
11.2 Post herpetic Neuralgia Treatment Key Raw Materials and Upstream Suppliers
11.3 Post herpetic Neuralgia Treatment Clients Analysis
11.4 Post herpetic Neuralgia Treatment Sales Channel and Sales Model Analysis
11.4.1 Post herpetic Neuralgia Treatment Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Post herpetic Neuralgia Treatment Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Post herpetic Neuralgia Treatment Distributors
12 Post herpetic Neuralgia Treatment Market Dynamics
12.1 Post herpetic Neuralgia Treatment Industry Trends
12.2 Post herpetic Neuralgia Treatment Market Drivers
12.3 Post herpetic Neuralgia Treatment Market Challenges
12.4 Post herpetic Neuralgia Treatment Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Post herpetic Neuralgia Treatment Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Post herpetic Neuralgia Treatment Market Size Growth by Distribution Channel (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Post herpetic Neuralgia Treatment Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Post herpetic Neuralgia Treatment Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Post herpetic Neuralgia Treatment Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Post herpetic Neuralgia Treatment Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Post herpetic Neuralgia Treatment Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2020-2025) & (US$ Million)
Table 9. Global Post herpetic Neuralgia Treatment Revenue Forecast by Distribution Channel (2026-2031) & (US$ Million)
Table 10. Post herpetic Neuralgia Treatment Revenue by Company (2020-2025) & (US$ Million)
Table 11. Post herpetic Neuralgia Treatment Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Post herpetic Neuralgia Treatment Players by Revenue (US$ Million) in 2024
Table 13. Global Post herpetic Neuralgia Treatment Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Post herpetic Neuralgia Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post herpetic Neuralgia Treatment as of 2024)
Table 15. Global Post herpetic Neuralgia Treatment Companies Headquarters
Table 16. Date of International Companies Enter into Post herpetic Neuralgia Treatment Market
Table 17. Global Post herpetic Neuralgia Treatment Companies Product & Service
Table 18. Global Post herpetic Neuralgia Treatment Mergers & Acquisitions, Expansion Plans
Table 19. Pfizer Corporation Information
Table 20. Pfizer Description and Business Overview
Table 21. Pfizer Post herpetic Neuralgia Treatment Product
Table 22. Pfizer Post herpetic Neuralgia Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Pfizer Revenue Proportion of Post herpetic Neuralgia Treatment by Product in 2024
Table 24. Pfizer Revenue Proportion of Post herpetic Neuralgia Treatment by Distribution Channel in 2024
Table 25. Pfizer Revenue Proportion of Post herpetic Neuralgia Treatment by Geographic Area in 2024
Table 26. Pfizer Recent Developments
Table 27. Arbor Pharma Corporation Information
Table 28. Arbor Pharma Description and Business Overview
Table 29. Arbor Pharma Post herpetic Neuralgia Treatment Product
Table 30. Arbor Pharma Post herpetic Neuralgia Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Arbor Pharma Revenue Proportion of Post herpetic Neuralgia Treatment by Product in 2024
Table 32. Arbor Pharma Revenue Proportion of Post herpetic Neuralgia Treatment by Distribution Channel in 2024
Table 33. Arbor Pharma Revenue Proportion of Post herpetic Neuralgia Treatment by Geographic Area in 2024
Table 34. Arbor Pharma Recent Developments
Table 35. Assertio Therapeutics Corporation Information
Table 36. Assertio Therapeutics Description and Business Overview
Table 37. Assertio Therapeutics Post herpetic Neuralgia Treatment Product
Table 38. Assertio Therapeutics Post herpetic Neuralgia Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Assertio Therapeutics Revenue Proportion of Post herpetic Neuralgia Treatment by Product in 2024
Table 40. Assertio Therapeutics Revenue Proportion of Post herpetic Neuralgia Treatment by Distribution Channel in 2024
Table 41. Assertio Therapeutics Revenue Proportion of Post herpetic Neuralgia Treatment by Geographic Area in 2024
Table 42. Assertio Therapeutics Recent Developments
Table 43. Endo Pharma Corporation Information
Table 44. Endo Pharma Description and Business Overview
Table 45. Endo Pharma Post herpetic Neuralgia Treatment Product
Table 46. Endo Pharma Post herpetic Neuralgia Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Endo Pharma Revenue Proportion of Post herpetic Neuralgia Treatment by Product in 2024
Table 48. Endo Pharma Revenue Proportion of Post herpetic Neuralgia Treatment by Distribution Channel in 2024
Table 49. Endo Pharma Revenue Proportion of Post herpetic Neuralgia Treatment by Geographic Area in 2024
Table 50. Endo Pharma Recent Developments
Table 51. Teikoku Pharma Corporation Information
Table 52. Teikoku Pharma Description and Business Overview
Table 53. Teikoku Pharma Post herpetic Neuralgia Treatment Product
Table 54. Teikoku Pharma Post herpetic Neuralgia Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Teikoku Pharma Revenue Proportion of Post herpetic Neuralgia Treatment by Product in 2024
Table 56. Teikoku Pharma Revenue Proportion of Post herpetic Neuralgia Treatment by Distribution Channel in 2024
Table 57. Teikoku Pharma Revenue Proportion of Post herpetic Neuralgia Treatment by Geographic Area in 2024
Table 58. Teikoku Pharma Recent Developments
Table 59. Teva Corporation Information
Table 60. Teva Description and Business Overview
Table 61. Teva Post herpetic Neuralgia Treatment Product
Table 62. Teva Post herpetic Neuralgia Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Teva Revenue Proportion of Post herpetic Neuralgia Treatment by Product in 2024
Table 64. Teva Revenue Proportion of Post herpetic Neuralgia Treatment by Distribution Channel in 2024
Table 65. Teva Revenue Proportion of Post herpetic Neuralgia Treatment by Geographic Area in 2024
Table 66. Teva Recent Developments
Table 67. Mylan Corporation Information
Table 68. Mylan Description and Business Overview
Table 69. Mylan Post herpetic Neuralgia Treatment Product
Table 70. Mylan Post herpetic Neuralgia Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Mylan Revenue Proportion of Post herpetic Neuralgia Treatment by Product in 2024
Table 72. Mylan Revenue Proportion of Post herpetic Neuralgia Treatment by Distribution Channel in 2024
Table 73. Mylan Revenue Proportion of Post herpetic Neuralgia Treatment by Geographic Area in 2024
Table 74. Mylan Recent Developments
Table 75. Hengrui Medicine Corporation Information
Table 76. Hengrui Medicine Description and Business Overview
Table 77. Hengrui Medicine Post herpetic Neuralgia Treatment Product
Table 78. Hengrui Medicine Post herpetic Neuralgia Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Hengrui Medicine Revenue Proportion of Post herpetic Neuralgia Treatment by Product in 2024
Table 80. Hengrui Medicine Revenue Proportion of Post herpetic Neuralgia Treatment by Distribution Channel in 2024
Table 81. Hengrui Medicine Revenue Proportion of Post herpetic Neuralgia Treatment by Geographic Area in 2024
Table 82. Hengrui Medicine Recent Developments
Table 83. North America Post herpetic Neuralgia Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 84. North America Post herpetic Neuralgia Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 85. North America Post herpetic Neuralgia Treatment Revenue by Type (2020-2025) & (US$ Million)
Table 86. North America Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2020-2025) & (US$ Million)
Table 87. Asia-Pacific Post herpetic Neuralgia Treatment Revenue by Region (2020-2025) & (US$ Million)
Table 88. Asia-Pacific Post herpetic Neuralgia Treatment Revenue by Region (2026-2031) & (US$ Million)
Table 89. Asia-Pacific Post herpetic Neuralgia Treatment Revenue by Type (2020-2025) & (US$ Million)
Table 90. Asia-Pacific Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2020-2025) & (US$ Million)
Table 91. Europe Post herpetic Neuralgia Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 92. Europe Post herpetic Neuralgia Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 93. Europe Post herpetic Neuralgia Treatment Revenue by Type (2020-2025) & (US$ Million)
Table 94. Europe Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2020-2025) & (US$ Million)
Table 95. Latin America Post herpetic Neuralgia Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 96. Latin America Post herpetic Neuralgia Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 97. Latin America Post herpetic Neuralgia Treatment Revenue by Type (2020-2025) & (US$ Million)
Table 98. Latin America Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2020-2025) & (US$ Million)
Table 99. Middle East and Africa Post herpetic Neuralgia Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 100. Middle East and Africa Post herpetic Neuralgia Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 101. Middle East and Africa Post herpetic Neuralgia Treatment Revenue by Type (2020-2025) & (US$ Million)
Table 102. Middle East and Africa Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2020-2025) & (US$ Million)
Table 103. Post herpetic Neuralgia Treatment Key Raw Materials, Industry Status and Trend
Table 104. Post herpetic Neuralgia Treatment Key Raw Materials and Upstream Suppliers
Table 105. Post herpetic Neuralgia Treatment Clients Status and Trend
Table 106. Post herpetic Neuralgia Treatment Typical Clients
Table 107. Post herpetic Neuralgia Treatment Distributors
Table 108. Post herpetic Neuralgia Treatment Market Trends
Table 109. Post herpetic Neuralgia Treatment Market Drivers
Table 110. Post herpetic Neuralgia Treatment Market Challenges
Table 111. Post herpetic Neuralgia Treatment Market Restraints
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Post herpetic Neuralgia Treatment Product Picture
Figure 2. Global Post herpetic Neuralgia Treatment Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Post herpetic Neuralgia Treatment Revenue Market Share by Type in 2024 & 2031
Figure 4. Anticonvulsants Product Picture
Figure 5. Skin Patch Product Picture
Figure 6. Other Product Picture
Figure 7. Global Post herpetic Neuralgia Treatment Market Size by Distribution Channel (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel in 2024 & 2031
Figure 9. Hospital Pharmacies
Figure 10. Online Pharmacies
Figure 11. Retail Pharmacies
Figure 12. Post herpetic Neuralgia Treatment Report Years Considered
Figure 13. Global Post herpetic Neuralgia Treatment Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Post herpetic Neuralgia Treatment Market Size (2020-2031) & (US$ Million)
Figure 15. Global Post herpetic Neuralgia Treatment Market Size Market Share by Region: 2024 Versus 2031
Figure 16. Global Post herpetic Neuralgia Treatment Revenue Market Share by Region (2020-2031)
Figure 17. Global Post herpetic Neuralgia Treatment Revenue Market Share Forecast by Type (2020-2031)
Figure 18. Global Post herpetic Neuralgia Treatment Revenue Market Share Forecast by Distribution Channel (2020-2031)
Figure 19. Anticonvulsants of Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel, 2024 VS 2031
Figure 20. Skin Patch of Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel, 2024 VS 2031
Figure 21. Other of Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel, 2024 VS 2031
Figure 22. Post herpetic Neuralgia Treatment Revenue Share by Company (2024)
Figure 23. Post herpetic Neuralgia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Anticonvulsants Revenue Proportion by Company in 2024
Figure 25. Skin Patch Revenue Proportion by Company in 2024
Figure 26. Other Revenue Proportion by Company in 2024
Figure 27. North America Post herpetic Neuralgia Treatment Revenue 2020-2031 (US$ Million)
Figure 28. North America Post herpetic Neuralgia Treatment Revenue Market Share by Type (2020-2025)
Figure 29. North America Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel (2020-2025)
Figure 30. Asia-Pacific Post herpetic Neuralgia Treatment Revenue 2020-2031 (US$ Million)
Figure 31. Asia-Pacific Post herpetic Neuralgia Treatment Revenue Market Share by Region (2020-2031)
Figure 32. Asia-Pacific Post herpetic Neuralgia Treatment Revenue Market Share by Type (2020-2025)
Figure 33. Asia-Pacific Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel (2020-2025)
Figure 34. Europe Post herpetic Neuralgia Treatment Revenue Growth Rate 2020-2031 (US$ Million)
Figure 35. Europe Post herpetic Neuralgia Treatment Revenue Market Share by Country (2020-2031)
Figure 36. Europe Post herpetic Neuralgia Treatment Revenue Market Share by Type (2020-2025)
Figure 37. Europe Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel (2020-2025)
Figure 38. Latin America Post herpetic Neuralgia Treatment Revenue Growth Rate 2020-2031 (US$ Million)
Figure 39. Latin America Post herpetic Neuralgia Treatment Revenue Market Share by Country (2020-2031)
Figure 40. Latin America Post herpetic Neuralgia Treatment Revenue Market Share by Type (2020-2025)
Figure 41. Latin America Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel (2020-2025)
Figure 42. Middle East and Africa Post herpetic Neuralgia Treatment Revenue Growth Rate 2020-2031 (US$ Million)
Figure 43. Middle East and Africa Post herpetic Neuralgia Treatment Revenue Market Share by Country (2020-2031)
Figure 44. Middle East and Africa Post herpetic Neuralgia Treatment Revenue Market Share by Type (2020-2025)
Figure 45. Middle East and Africa Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel (2020-2025)
Figure 46. Post herpetic Neuralgia Treatment Supply Chain (Upstream and Downstream Market)
Figure 47. Global Production Market Share of Post herpetic Neuralgia Treatment Raw Materials by Region in 2024
Figure 48. Post herpetic Neuralgia Treatment Distribution Channels
Figure 49. Global Post herpetic Neuralgia Treatment Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 50. Global Post herpetic Neuralgia Treatment Percentage 2020-2031: Online Sales VS Offline Sales
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Table 1. Global Post herpetic Neuralgia Treatment Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Post herpetic Neuralgia Treatment Market Size Growth by Distribution Channel (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Post herpetic Neuralgia Treatment Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Post herpetic Neuralgia Treatment Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Post herpetic Neuralgia Treatment Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Post herpetic Neuralgia Treatment Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Post herpetic Neuralgia Treatment Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2020-2025) & (US$ Million)
Table 9. Global Post herpetic Neuralgia Treatment Revenue Forecast by Distribution Channel (2026-2031) & (US$ Million)
Table 10. Post herpetic Neuralgia Treatment Revenue by Company (2020-2025) & (US$ Million)
Table 11. Post herpetic Neuralgia Treatment Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Post herpetic Neuralgia Treatment Players by Revenue (US$ Million) in 2024
Table 13. Global Post herpetic Neuralgia Treatment Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Post herpetic Neuralgia Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post herpetic Neuralgia Treatment as of 2024)
Table 15. Global Post herpetic Neuralgia Treatment Companies Headquarters
Table 16. Date of International Companies Enter into Post herpetic Neuralgia Treatment Market
Table 17. Global Post herpetic Neuralgia Treatment Companies Product & Service
Table 18. Global Post herpetic Neuralgia Treatment Mergers & Acquisitions, Expansion Plans
Table 19. Pfizer Corporation Information
Table 20. Pfizer Description and Business Overview
Table 21. Pfizer Post herpetic Neuralgia Treatment Product
Table 22. Pfizer Post herpetic Neuralgia Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Pfizer Revenue Proportion of Post herpetic Neuralgia Treatment by Product in 2024
Table 24. Pfizer Revenue Proportion of Post herpetic Neuralgia Treatment by Distribution Channel in 2024
Table 25. Pfizer Revenue Proportion of Post herpetic Neuralgia Treatment by Geographic Area in 2024
Table 26. Pfizer Recent Developments
Table 27. Arbor Pharma Corporation Information
Table 28. Arbor Pharma Description and Business Overview
Table 29. Arbor Pharma Post herpetic Neuralgia Treatment Product
Table 30. Arbor Pharma Post herpetic Neuralgia Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Arbor Pharma Revenue Proportion of Post herpetic Neuralgia Treatment by Product in 2024
Table 32. Arbor Pharma Revenue Proportion of Post herpetic Neuralgia Treatment by Distribution Channel in 2024
Table 33. Arbor Pharma Revenue Proportion of Post herpetic Neuralgia Treatment by Geographic Area in 2024
Table 34. Arbor Pharma Recent Developments
Table 35. Assertio Therapeutics Corporation Information
Table 36. Assertio Therapeutics Description and Business Overview
Table 37. Assertio Therapeutics Post herpetic Neuralgia Treatment Product
Table 38. Assertio Therapeutics Post herpetic Neuralgia Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Assertio Therapeutics Revenue Proportion of Post herpetic Neuralgia Treatment by Product in 2024
Table 40. Assertio Therapeutics Revenue Proportion of Post herpetic Neuralgia Treatment by Distribution Channel in 2024
Table 41. Assertio Therapeutics Revenue Proportion of Post herpetic Neuralgia Treatment by Geographic Area in 2024
Table 42. Assertio Therapeutics Recent Developments
Table 43. Endo Pharma Corporation Information
Table 44. Endo Pharma Description and Business Overview
Table 45. Endo Pharma Post herpetic Neuralgia Treatment Product
Table 46. Endo Pharma Post herpetic Neuralgia Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Endo Pharma Revenue Proportion of Post herpetic Neuralgia Treatment by Product in 2024
Table 48. Endo Pharma Revenue Proportion of Post herpetic Neuralgia Treatment by Distribution Channel in 2024
Table 49. Endo Pharma Revenue Proportion of Post herpetic Neuralgia Treatment by Geographic Area in 2024
Table 50. Endo Pharma Recent Developments
Table 51. Teikoku Pharma Corporation Information
Table 52. Teikoku Pharma Description and Business Overview
Table 53. Teikoku Pharma Post herpetic Neuralgia Treatment Product
Table 54. Teikoku Pharma Post herpetic Neuralgia Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Teikoku Pharma Revenue Proportion of Post herpetic Neuralgia Treatment by Product in 2024
Table 56. Teikoku Pharma Revenue Proportion of Post herpetic Neuralgia Treatment by Distribution Channel in 2024
Table 57. Teikoku Pharma Revenue Proportion of Post herpetic Neuralgia Treatment by Geographic Area in 2024
Table 58. Teikoku Pharma Recent Developments
Table 59. Teva Corporation Information
Table 60. Teva Description and Business Overview
Table 61. Teva Post herpetic Neuralgia Treatment Product
Table 62. Teva Post herpetic Neuralgia Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Teva Revenue Proportion of Post herpetic Neuralgia Treatment by Product in 2024
Table 64. Teva Revenue Proportion of Post herpetic Neuralgia Treatment by Distribution Channel in 2024
Table 65. Teva Revenue Proportion of Post herpetic Neuralgia Treatment by Geographic Area in 2024
Table 66. Teva Recent Developments
Table 67. Mylan Corporation Information
Table 68. Mylan Description and Business Overview
Table 69. Mylan Post herpetic Neuralgia Treatment Product
Table 70. Mylan Post herpetic Neuralgia Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Mylan Revenue Proportion of Post herpetic Neuralgia Treatment by Product in 2024
Table 72. Mylan Revenue Proportion of Post herpetic Neuralgia Treatment by Distribution Channel in 2024
Table 73. Mylan Revenue Proportion of Post herpetic Neuralgia Treatment by Geographic Area in 2024
Table 74. Mylan Recent Developments
Table 75. Hengrui Medicine Corporation Information
Table 76. Hengrui Medicine Description and Business Overview
Table 77. Hengrui Medicine Post herpetic Neuralgia Treatment Product
Table 78. Hengrui Medicine Post herpetic Neuralgia Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Hengrui Medicine Revenue Proportion of Post herpetic Neuralgia Treatment by Product in 2024
Table 80. Hengrui Medicine Revenue Proportion of Post herpetic Neuralgia Treatment by Distribution Channel in 2024
Table 81. Hengrui Medicine Revenue Proportion of Post herpetic Neuralgia Treatment by Geographic Area in 2024
Table 82. Hengrui Medicine Recent Developments
Table 83. North America Post herpetic Neuralgia Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 84. North America Post herpetic Neuralgia Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 85. North America Post herpetic Neuralgia Treatment Revenue by Type (2020-2025) & (US$ Million)
Table 86. North America Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2020-2025) & (US$ Million)
Table 87. Asia-Pacific Post herpetic Neuralgia Treatment Revenue by Region (2020-2025) & (US$ Million)
Table 88. Asia-Pacific Post herpetic Neuralgia Treatment Revenue by Region (2026-2031) & (US$ Million)
Table 89. Asia-Pacific Post herpetic Neuralgia Treatment Revenue by Type (2020-2025) & (US$ Million)
Table 90. Asia-Pacific Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2020-2025) & (US$ Million)
Table 91. Europe Post herpetic Neuralgia Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 92. Europe Post herpetic Neuralgia Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 93. Europe Post herpetic Neuralgia Treatment Revenue by Type (2020-2025) & (US$ Million)
Table 94. Europe Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2020-2025) & (US$ Million)
Table 95. Latin America Post herpetic Neuralgia Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 96. Latin America Post herpetic Neuralgia Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 97. Latin America Post herpetic Neuralgia Treatment Revenue by Type (2020-2025) & (US$ Million)
Table 98. Latin America Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2020-2025) & (US$ Million)
Table 99. Middle East and Africa Post herpetic Neuralgia Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 100. Middle East and Africa Post herpetic Neuralgia Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 101. Middle East and Africa Post herpetic Neuralgia Treatment Revenue by Type (2020-2025) & (US$ Million)
Table 102. Middle East and Africa Post herpetic Neuralgia Treatment Revenue by Distribution Channel (2020-2025) & (US$ Million)
Table 103. Post herpetic Neuralgia Treatment Key Raw Materials, Industry Status and Trend
Table 104. Post herpetic Neuralgia Treatment Key Raw Materials and Upstream Suppliers
Table 105. Post herpetic Neuralgia Treatment Clients Status and Trend
Table 106. Post herpetic Neuralgia Treatment Typical Clients
Table 107. Post herpetic Neuralgia Treatment Distributors
Table 108. Post herpetic Neuralgia Treatment Market Trends
Table 109. Post herpetic Neuralgia Treatment Market Drivers
Table 110. Post herpetic Neuralgia Treatment Market Challenges
Table 111. Post herpetic Neuralgia Treatment Market Restraints
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Post herpetic Neuralgia Treatment Product Picture
Figure 2. Global Post herpetic Neuralgia Treatment Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Post herpetic Neuralgia Treatment Revenue Market Share by Type in 2024 & 2031
Figure 4. Anticonvulsants Product Picture
Figure 5. Skin Patch Product Picture
Figure 6. Other Product Picture
Figure 7. Global Post herpetic Neuralgia Treatment Market Size by Distribution Channel (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel in 2024 & 2031
Figure 9. Hospital Pharmacies
Figure 10. Online Pharmacies
Figure 11. Retail Pharmacies
Figure 12. Post herpetic Neuralgia Treatment Report Years Considered
Figure 13. Global Post herpetic Neuralgia Treatment Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Post herpetic Neuralgia Treatment Market Size (2020-2031) & (US$ Million)
Figure 15. Global Post herpetic Neuralgia Treatment Market Size Market Share by Region: 2024 Versus 2031
Figure 16. Global Post herpetic Neuralgia Treatment Revenue Market Share by Region (2020-2031)
Figure 17. Global Post herpetic Neuralgia Treatment Revenue Market Share Forecast by Type (2020-2031)
Figure 18. Global Post herpetic Neuralgia Treatment Revenue Market Share Forecast by Distribution Channel (2020-2031)
Figure 19. Anticonvulsants of Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel, 2024 VS 2031
Figure 20. Skin Patch of Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel, 2024 VS 2031
Figure 21. Other of Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel, 2024 VS 2031
Figure 22. Post herpetic Neuralgia Treatment Revenue Share by Company (2024)
Figure 23. Post herpetic Neuralgia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Anticonvulsants Revenue Proportion by Company in 2024
Figure 25. Skin Patch Revenue Proportion by Company in 2024
Figure 26. Other Revenue Proportion by Company in 2024
Figure 27. North America Post herpetic Neuralgia Treatment Revenue 2020-2031 (US$ Million)
Figure 28. North America Post herpetic Neuralgia Treatment Revenue Market Share by Type (2020-2025)
Figure 29. North America Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel (2020-2025)
Figure 30. Asia-Pacific Post herpetic Neuralgia Treatment Revenue 2020-2031 (US$ Million)
Figure 31. Asia-Pacific Post herpetic Neuralgia Treatment Revenue Market Share by Region (2020-2031)
Figure 32. Asia-Pacific Post herpetic Neuralgia Treatment Revenue Market Share by Type (2020-2025)
Figure 33. Asia-Pacific Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel (2020-2025)
Figure 34. Europe Post herpetic Neuralgia Treatment Revenue Growth Rate 2020-2031 (US$ Million)
Figure 35. Europe Post herpetic Neuralgia Treatment Revenue Market Share by Country (2020-2031)
Figure 36. Europe Post herpetic Neuralgia Treatment Revenue Market Share by Type (2020-2025)
Figure 37. Europe Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel (2020-2025)
Figure 38. Latin America Post herpetic Neuralgia Treatment Revenue Growth Rate 2020-2031 (US$ Million)
Figure 39. Latin America Post herpetic Neuralgia Treatment Revenue Market Share by Country (2020-2031)
Figure 40. Latin America Post herpetic Neuralgia Treatment Revenue Market Share by Type (2020-2025)
Figure 41. Latin America Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel (2020-2025)
Figure 42. Middle East and Africa Post herpetic Neuralgia Treatment Revenue Growth Rate 2020-2031 (US$ Million)
Figure 43. Middle East and Africa Post herpetic Neuralgia Treatment Revenue Market Share by Country (2020-2031)
Figure 44. Middle East and Africa Post herpetic Neuralgia Treatment Revenue Market Share by Type (2020-2025)
Figure 45. Middle East and Africa Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel (2020-2025)
Figure 46. Post herpetic Neuralgia Treatment Supply Chain (Upstream and Downstream Market)
Figure 47. Global Production Market Share of Post herpetic Neuralgia Treatment Raw Materials by Region in 2024
Figure 48. Post herpetic Neuralgia Treatment Distribution Channels
Figure 49. Global Post herpetic Neuralgia Treatment Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 50. Global Post herpetic Neuralgia Treatment Percentage 2020-2031: Online Sales VS Offline Sales
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Benzyltrimethylammonium Hydroxide (BTMAH) Market Research Report 2025
Jul 10, 25
Global Allyltrimethylammonium Chloride Market Research Report 2025
Jul 10, 25
Global Calcium Bisglycinate Market Research Report 2025
Jul 10, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232